Medication info
Beatorin Tablets 10/10

Beatorin Tablets 10/10

Prescription medicationTabletOral
Ingredient · strength
Simvastatin›10mg / 1 tabletEzetimibe›10mg / 1 tablet
Manufacturer / importer
Daewoong Bio Co., Ltd.
Appearance
White to pale yellow, double convex, rectangular tablets
Packaging
30 tablets (10 tablets/PTPX3)
Approval status
Active

MFDS item code 201601729 · Approved 2016.03.31 · Insurance code 694001030

Summary

Main use
Improvement of hypercholesterolemia (primary and homozygous familial) and mixed dyslipidemia
Who takes it
Adults
Adult dose
Patients taking this medicine must follow a standard cholesterol-lowering diet before and during treatment. The dosage of this medicine should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. This medicine is administered once daily in the evening, with or without food. 1. Patients with primary hypercholesterolemia The dosage range for this medicine is 10/10mg~10/40mg once daily. The generally recommended initial dose is 10/20mg once daily. For patients who require less LDL cholesterol reduction, treatment may be initiated at 10/10mg once daily. After starting treatment with this medicine or adjusting the dose, check blood lipid levels after an interval of at least 4 weeks and then adjust the dose. Due to the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this medicine should be administered only to patients who have taken 10/80 mg of this medicine for 12 months or longer without evidence of muscle toxicity (see Precautions for Use, 1. Warnings). 2. Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg once daily, administered in the evening. This medicine is used as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not useful. 3. Administration to patients with hepatic impairment No dosage adjustment is necessary for patients with mild hepatic impairment; however, this medicine is not recommended for patients with moderate or severe hepatic impairment (see Precautions for Use, 5. General Precautions, Patients with Abnormal Liver Function). 4. Administration to patients with renal impairment and patients with chronic kidney disease No dosage adjustment is necessary for patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). For patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡, administer 10/20mg of this medicine once daily in the evening. When administering higher doses of this medicine to these patients, use caution and monitor them closely (see Precautions for Use, 5. General Precautions). 5. Administration to elderly patients No dosage adjustment is necessary for elderly patients. 6. Concomitant administration with other medicines (See Precautions for Use, 6. Interactions.) This medicine should be administered at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant. Patients receiving this medicine concomitantly with verapamil, diltiazem, or dronedarone should not exceed a dose of 10/10mg/day of this medicine. Patients receiving this medicine concomitantly with amiodarone, amlodipine, or ranolazine should not exceed 10/20mg/day of this medicine.

Ingredients

Manufacturer
Daewoong Bio Co., Ltd.

Efficacy & effects

Improvement of hypercholesterolemia (primary and homozygous familial) and mixed dyslipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed hyperlipidemia
  • homozygous familial hypercholesterolemia
  • increased risk of atherosclerotic vascular disease due to hypercholesterolemia
View approved original text

This medication is used as an adjunct to dietary therapy to lower blood cholesterol and triglyceride levels in patients with primary hypercholesterolemia and mixed hyperlipidemia, and to increase levels of HDL, the 'good' cholesterol. It can be administered to patients with hypercholesterolemia, including those with familial hypercholesterolemia. Additionally, this medication may be used as an adjunctive treatment in patients with homozygous familial hypercholesterolemia when other therapies are ineffective. It should be safely used in conjunction with lipid-regulating medications when there is a high risk of atherosclerotic vascular disease due to hypercholesterolemia. It is important to identify and treat other causes of cholesterol abnormalities before using the medication, and using it in conjunction with dietary therapy is effective. This medication helps improve cardiovascular health by controlling blood lipid levels.

How to take

Adult dose

Patients taking this medicine must follow a standard cholesterol-lowering diet before and during treatment. The dosage of this medicine should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. This medicine is administered once daily in the evening, with or without food. 1. Patients with primary hypercholesterolemia The dosage range for this medicine is 10/10mg~10/40mg once daily. The generally recommended initial dose is 10/20mg once daily. For patients who require less LDL cholesterol reduction, treatment may be initiated at 10/10mg once daily. After starting treatment with this medicine or adjusting the dose, check blood lipid levels after an interval of at least 4 weeks and then adjust the dose. Due to the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this medicine should be administered only to patients who have taken 10/80 mg of this medicine for 12 months or longer without evidence of muscle toxicity (see Precautions for Use, 1. Warnings). 2. Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg once daily, administered in the evening. This medicine is used as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not useful. 3. Administration to patients with hepatic impairment No dosage adjustment is necessary for patients with mild hepatic impairment; however, this medicine is not recommended for patients with moderate or severe hepatic impairment (see Precautions for Use, 5. General Precautions, Patients with Abnormal Liver Function). 4. Administration to patients with renal impairment and patients with chronic kidney disease No dosage adjustment is necessary for patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). For patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡, administer 10/20mg of this medicine once daily in the evening. When administering higher doses of this medicine to these patients, use caution and monitor them closely (see Precautions for Use, 5. General Precautions). 5. Administration to elderly patients No dosage adjustment is necessary for elderly patients. 6. Concomitant administration with other medicines (See Precautions for Use, 6. Interactions.) This medicine should be administered at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant. Patients receiving this medicine concomitantly with verapamil, diltiazem, or dronedarone should not exceed a dose of 10/10mg/day of this medicine. Patients receiving this medicine concomitantly with amiodarone, amlodipine, or ranolazine should not exceed 10/20mg/day of this medicine.

Precautions

This medication may cause serious muscle-related side effects such as myopathy and rhabdomyolysis, so if muscle pain or weakness is experienced, consult a physician immediately. Patients with allergies to this medication's ingredients, those with active liver disease, or those with persistent unexplained elevations in liver enzyme levels should not take this medication. Pregnant or breastfeeding women should not take this medication, and women who may become pregnant should consult their physician before taking it and use appropriate contraception. If taking medications that interfere with the metabolism of this medication in the liver, such as certain antifungals, antibiotics, antiviral drugs, or immunosuppressants, the risk of side effects may increase, so it is essential to inform the physician about all medications being taken. Elderly patients, those with poor kidney function, and patients with thyroid dysfunction should use this medication with caution as the risk of side effects may be higher. Regular monitoring of liver function and muscle status is necessary while taking this medication, and if any abnormalities are found, consult a physician immediately. Side effects such as diarrhea, headache, muscle pain, and cold symptoms may occur, and if symptoms worsen or persist, inform a physician. This medication contains lactose, so patients with lactose intolerance should not take it. Caution should be exercised if taken with grapefruit juice or certain medications, as this may increase drug concentration and the risk of side effects. When starting or discontinuing any new medications while taking this drug, always consult healthcare professionals and do not stop taking it arbitrarily.

Side effects

  • Myopathy
  • rhabdomyolysis
  • elevated creatine kinase
  • headache
  • diarrhea
  • influenza
  • upper respiratory infection
  • myalgia
  • limb pain
  • fatigue
Show 88 more
  • abdominal pain
  • viral infection
  • pharyngitis
  • sinusitis
  • arthralgia
  • low back pain
  • cough
  • anaphylaxis
  • urticaria
  • rash
  • angioedema
  • elevated liver aminotransferase levels
  • hepatitis
  • thrombocytopenia
  • nausea
  • pancreatitis
  • dizziness
  • paresthesia
  • depression
  • cholelithiasis
  • cholecystitis
  • mucocutaneous syndrome
  • toxic epidermal necrolysis
  • eosinophilia
  • drug reaction with systemic symptoms
  • erythema multiforme
  • myasthenia
  • cataract
  • constipation
  • dyspepsia
  • flatulence
  • nausea
  • eczema
  • pruritus
  • rash
  • muscle cramps
  • arthritis
  • tremor
  • peripheral neuropathy
  • peripheral neuropathy paralysis
  • mental disorder
  • anxiety
  • sleep disorder
  • memory impairment
  • forgetfulness
  • amnesia
  • memory dysfunction
  • confusion
  • interstitial lung disease
  • thrombocytopenia
  • leukopenia
  • hemolytic anemia
  • positive antinuclear antibodies
  • increased erythrocyte sedimentation rate
  • photosensitivity
  • fever
  • chills
  • flushing
  • fatigue
  • dyspnea
  • cholestatic jaundice
  • liver fat changes
  • cirrhosis
  • fulminant hepatic necrosis
  • liver cancer
  • liver failure
  • alopecia
  • various skin changes
  • lichen planus-like drug rash
  • gynecomastia
  • decreased libido
  • sexual dysfunction
  • ocular muscle paralysis
  • anemia
  • elevated serum creatine phosphokinase
  • weight loss
  • edema
  • thirst
  • facial swelling
  • syncope
  • insomnia
  • gastritis
  • atrophic gastritis
  • mucous stools
  • irritable bowel syndrome
  • sore throat
  • nocturia
  • hematuria

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to air and moisture, so it should be stored in a tightly sealed container. The appropriate storage temperature is room temperature between 1 degree and 30 degrees Celsius, and it is best to avoid extremely hot or humid places.

Appearance and packaging

Appearance

White to pale yellow, double convex, rectangular tablets

Package unit

30 tablets (10 tablets/PTPX3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.